Drug repurposing against COVID-19. focus on anticancer agents
01 Pubblicazione su rivista
Ciliberto Gennaro, Mancini Rita, Paggi Marco G
ISSN: 1756-9966
The very limited time allowed to face the COVID-19 pandemic poses a pressing challenge to find proper therapeutic approaches. However, synthesis and full investigation from preclinical studies to phase III trials of new medications is a time-consuming procedure, and not viable in a global emergency, such as the one we are facing.